Arylalkanolamines (ArROHNR2) are a class of medicinal molecules that are structurally related to one another in certain respects.
Detailed understanding of their structure-activity relationship is expected to aid in drug discovery.[citation needed]
| Compound | Group | 1/2/3° OH | Α/Β/Γ/Δ | Α/Β/Γ/Δ | N | Type of Pharmacology |
| PRC025 | 3-OH-2-BN-A | 2° | γ-aminoalcohol | β | NHMe2 | SN(D)RI |
| PRC200-SS | PP-3-A | 2° | " | α,β | NHMe | NS(D)RI |
| Pridinol | " | 3° | " | NC5H10 | Anticholinergic (NMDA?) | |
| Trihexyphenidyl (aka Benzhexol) | " | " | " | " | " | |
| Biperiden | " | " | " | " | " | |
| BDPC | cyclohexanol | 3° | δ-aminoalcohol | γ,δ | NMe2 | μ/delta-opioid agonist |
| Tramadol | " | " | 3 | α-arylalcohol | " | μ-opioid agonist(prodrug, M1SNRI |
| Venlafaxine | " | " | 2 | β-arylalcohol | " | SNRI |
| Ciramadol | " | 2° | 3 | γ-arylalcohol | " | μ-opioid mixed ant/agonist |
| Phenylpropanolamine | PP-2-A | 2° | 2 | NH2 | nor/adrenergic releaser | |
| Cathine | " | " | " | " | nor/adrenergic releaser | |
| Ephedrine | " | " | β-aminoalcohol | NHMe | nor/adrenergic releaser | |
| Pseudoephedrine | " | " | " | " | nor/adrenergic releaser | |
| Dopamine | " | " | " | " | endogenous neurotransmitter | |
| Epinephrine | ArE-2-A | " | " | " | neurotransmitter, also a hormone | |
| Norepinephrine | " | " | " | NH2 | neurotransmitter | |
| Synephrine | " | " | " | " | α1 agonist | |
| Phenylephrine | " | " | " | " | α1 agonist | |
| Levalbuterol | " | " | " | NH(t-Bu) | β-agonist | |
| Clenbuterol | " | " | " | " | " | |
| Haloperidol | Piperidinol | 3° | δ | 4,4 | piper | DA antagonist |
| Loperamide(Imodium AD) | " | " | " | " | " | μ-opioid agonist. |